Skip to main content
Clinical Trials/ISRCTN17344943
ISRCTN17344943CompletedNot Applicable

Evaluation of the gastrointestinal effects of breads containing in situ produced arabinoxylan-oligosaccharides in healthy volunteers: a monocentric, randomised, double-blind, controlled cross-over study

Puracor NV (Belgium)0 sites25 target enrollmentStarted: June 6, 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
25

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Age between 18 and 46 years
  • 2. Good general health (determined by self-assessment)
  • 3. Regular eating habit (3 meals per day during at least 5 days per week)

Exclusion Criteria

  • 1. History of abdominal surgery
  • 2. Intake of antibiotics less than two months before the start of the study
  • 3. Medical treatments influencing gut transit less than 2 weeks before the start of the study

Investigators

Sponsor
Puracor NV (Belgium)

Similar Trials